Thiazolidinediones and fracture risk in patients with Type 2 diabetes von Betteridge, D. J.

Volltext

What is oxidative stress? von Betteridge, D. John

Volltext

Is the ADA/EASD algorithm for the management of type 2 diabetes (January 2009) based on evidence or opinion? A critical analysis von Schernthaner, G, Barnett, A. H, Betteridge, D. J, Carmena, R, Ceriello, A, Charbonnel, B, Hanefeld, M, Lehmann, R, Malecki, M. T, Nesto, R, Pirags, V, Scheen, A, Seufert, J, Sjohölm, A, Tsatsoulis, A, DeFronzo, R

Volltext

Genetic causes of familial hypercholesterolaemia in patients in the UK: relation to plasma lipid levels and coronary heart disease risk von Humphries, S E, Whittall, R A, Hubbart, C S, Maplebeck, S, Cooper, J A, Soutar, A K, Naoumova, R, Thompson, G R, Seed, M, Durrington, P N, Miller, J P, Betteridge, D J B, Neil, H A W

Volltext

Association between serum levels of soluble receptor for advanced glycation end products and circulating advanced glycation end products in type 2 diabetes von TAN, K. C. B, SHIU, S. W. M, CHOW, W. S, LENG, L, BUCALA, R, BETTERIDGE, D. J

Volltext

Impact of peripheral arterial disease in patients with diabetes—Results from PROactive (PROactive 11) von Dormandy, J.A, Betteridge, D.J, Schernthaner, G, Pirags, V, Norgren, L

Volltext

Effect of insulin on the soluble receptor for advanced glycation end products (RAGE) von Lam, J. K. Y., Wang, Y., Shiu, S. W. M., Wong, Y., Betteridge, D. J., Tan, K. C. B.

Volltext

Long-term effects on lipids and lipoproteins of pioglitazone versus gliclazide addition to metformin and pioglitazone versus metformin addition to sulphonylurea in the treatment of... von BETTERIDGE, D. J, VERGES, B

Volltext

Effects of atorvastatin on serum soluble receptors for advanced glycation end-products in type 2 diabetes von Tam, H.L, Shiu, S.W.M, Wong, Y, Chow, W.S, Betteridge, D.J, Tan, K.C.B

Volltext

Thiazolidinedione increases serum soluble receptor for advanced glycation end-products in type 2 diabetes von Tan, K. C. B, Chow, W. S, Tso, A. W. K, Xu, A, Tse, H. F, Hoo, R. L. C, Betteridge, D. J, Lam, K. S. L

Volltext

Relationships between plasma measures of oxidative stress and metabolic control in NIDDM von NOUROOZ-ZADEH, J, RAHIMI, A, TAJADDINI-SARMADI, J, TRITSCHLER, H, ROSEN, P, HALLIWELL, B, BETTERIDGE, D. J

Volltext

Effects of rosuvastatin on lipids, lipoproteins and apolipoproteins in the dyslipidaemia of diabetes von Betteridge, D. J., Gibson, J. M.

Volltext

Long-term glycaemic control with metformin-sulphonylurea-pioglitazone triple therapy in PROactive (PROactive 17) von Scheen, A. J., Tan, M. H., Betteridge, D. J., Birkeland, K., Schmitz, O., Charbonnel, B.

Volltext

All-cause and cardiovascular mortality in treated patients with severe hypertriglyceridaemia: A long-term prospective registry study von Neil, H.A.W, Cooper, J, Betteridge, D.J, Capps, N, McDowell, I.F.W, Durrington, P.N, Seed, M, Mann, J.I, Humphries, S.E

Volltext

effect of sensitisation to insulin with pioglitazone on fasting and postprandial lipid metabolism, lipoprotein modification by lipases, and lipid transfer activities in type 2 diab... von Majali, K. Al, Cooper, M. B, Staels, B, Luc, G, Taskinen, M-R, Betteridge, D. J

Volltext

Rapid emergence of effect of atorvastatin on cardiovascular outcomes in the Collaborative Atorvastatin Diabetes Study (CARDS) von Colhoun, H. M, Betteridge, D. J, Durrington, P. N, Hitman, G. A, Neil, H. A. W, Livingstone, S. J, Thomason, M. J, Fuller, J. H

Volltext

Established and emerging coronary risk factors in patients with heterozygous familial hypercholesterolaemia von Neil, H A W, Seagroatt, V, Betteridge, D J, Cooper, M P, Durrington, P N, Miller, J P, Seed, M, Naoumova, R P, Thompson, G R, Huxley, R, Humphries, S E

Volltext

Reflux episodes detected by impedance in patients on and off esomeprazole: a randomised double‐blinded placebo‐controlled crossover study von Moawad, F. J., Betteridge, J. D., Boger, J. A., Cheng, F.‐K. F., Belle, L. S., Chen, Y.‐J., Maydonovitch, C. L., Wong, R. K. H.

Volltext

Apolipoproteins, cardiovascular risk and statin response in type 2 diabetes: the Collaborative Atorvastatin Diabetes Study (CARDS) von Charlton-Menys, V, Betteridge, D. J, Colhoun, H, Fuller, J, France, M, Hitman, G. A, Livingstone, S. J, Neil, H. A. W, Newman, C. B, Szarek, M, DeMicco, D. A, Durrington, P. N

Volltext

The effect of atorvastatin on serum lipids, lipoproteins and NMR spectroscopy defined lipoprotein subclasses in type 2 diabetic patients with ischaemic heart disease von Soedamah-Muthu, S.S., Colhoun, H.M., Thomason, M.J., Betteridge, D.J., Durrington, P.N., Hitman, G.A., Fuller, J.H., Julier, K., Mackness, M.I., Neil, H.A.W.

Volltext